SCHEMBL25454622

SCHEMBL25454622

CCNC(CC(=O)NC(c1ccccc1)(c1ccccc1)c1ccccc1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNN4 O15554 2/20 0.42
▸ MAPT P10636 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MMP2 P08253 2/20 0.35
▸ MMP9 P14780 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ POLB P06746 2/20 0.35
▸ GRIN2D O15399 2/20 0.35
▸ GRIN1 Q05586 2/20 0.35
▸ GRIN2A Q12879 2/20 0.35
▸ GRIN2B Q13224 2/20 0.35
▸ GRIN2C Q14957 2/20 0.35
▸ OPRM1 P35372 2/20 0.35
▸ KIF11 P52732 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13261078 0.85 NPSR1 (0.43) KCNN4MAPTNPSR1MMP2MMP9
SCHEMBL25454619 0.85 NPSR1 (0.43) KCNN4MAPTNPSR1MMP2MMP9
SCHEMBL23901507 0.82 HPGD (0.42) KCNN4MAPTNPSR1LMNAGRIN2D
SCHEMBL29401794 0.82 NPSR1 (0.41) MAPTNPSR1SMN1; SMN2RECQLCACNA1C
SCHEMBL23901644 0.81 MAPT (0.40) KCNN4MAPTNPSR1SMN1; SMN2LMNA
SCHEMBL26292979 0.78 APAF1 (0.42) KCNN4MAPTRAB9ALMNAGRIN2D
SCHEMBL12038615 0.78 APAF1 (0.42) KCNN4MAPTRAB9ALMNAGRIN2D
SCHEMBL14434125 0.78 MAPT (0.39) KCNN4MAPTNPSR1NPC1LMNA
SCHEMBL19455846 0.77 C3AR1 (0.40) NPSR1ACE
SCHEMBL21724720 0.77 ACE (0.53) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ NATIONAL INSTITUTES OF HEALTH 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ HAVCR2, CD44, ENGASE KCNN4 4764/4885MAPT 4460/4885NPSR1 2850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback